Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero

被引:5
作者
Rodewald, Lance E. [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, China CDC, Natl Immunizat Program, Dept Natl Immunizat Program, 155 Changbai Rd, Beijing 102206, Peoples R China
关键词
Vaccines; Immunization; Immunization program; Immunization Agenda 2030; COVID-19; Life course vaccination;
D O I
10.1186/s40249-023-01151-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
China's immunization programs conducted a unified, tightly coordinated COVID-19 vaccination campaign during the dynamic COVID Zero period that reached well over 90% of the population with vaccines having > 90% effectiveness against serious-to-fatal COVID-19. The campaign was eight times the size of the annual routine national immunization program, administering 3.4 billion doses of vaccines while monitoring vaccine coverage, acceptability, safety, and effectiveness. Every asset of the routine immunization program had to be strengthened and expanded to attain high coverage and reach hundreds of millions of adults who had not been vaccinated since childhood. Program strengthening and expansion were in directions aligned with the World Health Organization's Immunization Agenda 2030, which has a vision that "everyone, everywhere, at every age fully benefits from vaccines for good health and well-being" and requires reaching all children, adolescents, and adults with lifesaving vaccines. Momentum from this campaign should not be lost but should be invested into achieving what is possible with a properly resourced national immunization program that is now proven to be capable of reaching everyone in the world's largest country throughout the life course, and to do so with all vaccines recommended by the World Health Organization.
引用
收藏
页数:4
相关论文
共 16 条
[1]   Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China [J].
An, Zhijie ;
Wang, Fuzhen ;
Pan, An ;
Yin, Zundong ;
Rodewald, Lance ;
Feng, Zijian .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 375
[2]  
[Anonymous], 2018, Polio Post-Certification Strategy: a risk mitigation strategy for a polio-free world
[3]  
[Anonymous], ABOUT US
[4]   Developing an effective and sustainable national immunisation programme in China: issues and challenges [J].
Chen, Shu ;
Yao, Laiang ;
Wang, Weibing ;
Tang, Shenglan .
LANCET PUBLIC HEALTH, 2022, 7 (12) :E1064-E1072
[5]  
China CDC, China CDC Weekly under COVID-19 section
[6]   Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China [J].
Dai, Peixi ;
Wang, Qing ;
Jia, Mengmeng ;
Leng, Zhiwei ;
Xie, Shuyun ;
Feng, Luzhao ;
Yang, Weizhong .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
[7]   China has the momentum to eliminate measles [J].
Durrheim, David N. ;
Xu, Aiqiang ;
Baker, Michael G. ;
Hsu, Li Yang ;
Takashima, Yoshihiro .
LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 30
[8]  
Feng ZJ, 2019, CHINA CDC WEEKLY, V1, P17
[9]   Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death [J].
Huang, Zhuoying ;
Xu, Shuangfei ;
Liu, Jiechen ;
Wu, Linlin ;
Qiu, Jing ;
Wang, Nan ;
Ren, Jia ;
Li, Zhi ;
Guo, Xiang ;
Tao, Fangfang ;
Chen, Jian ;
Lu, Donglei ;
Sun, Xiaodong ;
Wang, Weibing .
BMC MEDICINE, 2022, 20 (01)
[10]  
Information Office Henan Provincial Government, Henan has passed the peak of the epidemic and the infection rate of the SARS-CoV-2 is 89.0%